Current and historical daily PE Ratio for UTHR (
United Therapeutics Corp
) from 1999 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. United Therapeutics stock (UTHR) PE ratio as of Apr 25 2024 is 11.94.
More Details
United Therapeutics Corp (UTHR) PE Ratio (TTM) Chart
United Therapeutics Corp (UTHR) PE Ratio (TTM) Historical Data
View and export this data going back to 1999. Start your Free Trial
Total 1215
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| United Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 11.9 | 2024-02-21 | 11.1 |
| 2024-04-24 | 11.9 | 2024-02-20 | 10.8 |
| 2024-04-23 | 11.8 | 2024-02-16 | 10.8 |
| 2024-04-22 | 11.8 | 2024-02-15 | 10.8 |
| 2024-04-19 | 12.0 | 2024-02-14 | 10.8 |
| 2024-04-18 | 11.9 | 2024-02-13 | 10.8 |
| 2024-04-17 | 11.9 | 2024-02-12 | 10.9 |
| 2024-04-16 | 11.7 | 2024-02-09 | 10.7 |
| 2024-04-15 | 11.8 | 2024-02-08 | 10.7 |
| 2024-04-12 | 11.7 | 2024-02-07 | 10.6 |
| 2024-04-11 | 12.0 | 2024-02-06 | 10.8 |
| 2024-04-10 | 12.0 | 2024-02-05 | 10.7 |
| 2024-04-09 | 11.9 | 2024-02-02 | 10.8 |
| 2024-04-08 | 11.9 | 2024-02-01 | 10.9 |
| 2024-04-05 | 11.8 | 2024-01-31 | 10.8 |
| 2024-04-04 | 11.8 | 2024-01-30 | 10.8 |
| 2024-04-03 | 11.7 | 2024-01-29 | 10.9 |
| 2024-04-02 | 11.5 | 2024-01-26 | 11.0 |
| 2024-04-01 | 11.5 | 2024-01-25 | 11.1 |
| 2024-03-28 | 11.6 | 2024-01-24 | 11.0 |
| 2024-03-27 | 12.3 | 2024-01-23 | 11.0 |
| 2024-03-26 | 12.5 | 2024-01-22 | 10.9 |
| 2024-03-25 | 12.3 | 2024-01-19 | 11.0 |
| 2024-03-22 | 12.0 | 2024-01-18 | 11.0 |
| 2024-03-21 | 11.9 | 2024-01-17 | 11.2 |
| 2024-03-20 | 11.9 | 2024-01-16 | 11.0 |
| 2024-03-19 | 12.1 | 2024-01-12 | 11.0 |
| 2024-03-18 | 11.8 | 2024-01-11 | 11.1 |
| 2024-03-15 | 11.9 | 2024-01-10 | 11.2 |
| 2024-03-14 | 12.0 | 2024-01-09 | 11.3 |
| 2024-03-13 | 12.2 | 2024-01-08 | 11.7 |
| 2024-03-12 | 12.4 | 2024-01-05 | 11.6 |
| 2024-03-11 | 12.6 | 2024-01-04 | 11.6 |
| 2024-03-08 | 12.3 | 2024-01-03 | 11.5 |
| 2024-03-07 | 12.1 | 2024-01-02 | 11.5 |
| 2024-03-06 | 11.9 | 2023-12-29 | 11.1 |
| 2024-03-05 | 11.6 | 2023-12-28 | 11.1 |
| 2024-03-04 | 11.5 | 2023-12-27 | 11.8 |
| 2024-03-01 | 11.7 | 2023-12-26 | 11.9 |
| 2024-02-29 | 11.4 | 2023-12-22 | 12.1 |
| 2024-02-28 | 11.5 | 2023-12-21 | 12.0 |
| 2024-02-27 | 11.4 | 2023-12-20 | 12.4 |
| 2024-02-26 | 11.3 | 2023-12-19 | 13.2 |
| 2024-02-23 | 11.4 | 2023-12-18 | 13.6 |
| 2024-02-22 | 11.0 | 2023-12-15 | 13.6 |
United Therapeutics Corp (UTHR) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
United Therapeutics Corp
NAICS : 325412
SIC : 2834
ISIN : US91307C1027
Share Class Description:
UTHR: Ordinary SharesCompare
Compare
Traded in other countries / regions
UTHR.USAU2TH34.BrazilUTH.Germany IPO Date
1999-06-17Description
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers